Portal de Periódicos da CAPES

Matrix Metalloproteinase Hypothesis of Plaque Rupture

2001; Lippincott Williams & Wilkins; Volume: 104; Issue: 16 Linguagem: Inglês

10.1161/circ.104.16.1878

1524-4539

Prediman K. Shah, Zorina S. Galis,

Coronary Interventions and Diagnostics

HomeCirculationVol. 104, No. 16Matrix Metalloproteinase Hypothesis of Plaque Rupture Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBMatrix Metalloproteinase Hypothesis of Plaque RupturePlayers Keep Piling Up But Questions Remain Prediman K. Shah, MD and Zorina S. Galis, PhD Prediman K. ShahPrediman K. Shah From the Atherosclerosis Research Center, Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, Calif (P.K.S.), and the Departments of Medicine and Biomedical Engineering, Emory University School of Medicine, Atlanta, Ga (Z.S.G.). and Zorina S. GalisZorina S. Galis From the Atherosclerosis Research Center, Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, Calif (P.K.S.), and the Departments of Medicine and Biomedical Engineering, Emory University School of Medicine, Atlanta, Ga (Z.S.G.). Originally published16 Oct 2001https://doi.org/10.1161/circ.104.16.1878Circulation. 2001;104:1878–1880Arterial thrombosis is generally recognized as the proximate event responsible for most acute ischemic syndromes resulting from atherosclerotic vascular disease.1,2 The majority of such thrombi (60% to 80%) occur at sites of fissure or rupture of a thinned fibrous cap overlying a lipid-rich atherosclerotic lesion with intimal and adventitial inflammation, and the remainder occur over areas of superficial plaque erosion.1–5 The severity of luminal stenosis produced by such lesions before plaque rupture is frequently only mild or moderate, although the plaques tend to be large, and this seeming paradox is mostly because of the outward remodeling of the vessel wall.1,6,7See p 1899The precise mechanism(s) responsible for plaque rupture remain to be defined; however, the excessive degradation of the extracellular matrix scaffold has been implicated as one of the major molecular mechanisms in this process. A likely culprit is a family of matrix-degrading metalloproteinases (MMPs) expressed in human atherosclerotic lesions around the lipid core; they generally colocalize with macrophages/foam cells and, to a lesser extent, with smooth muscle cells and endothelial cells.8–11 Further suggesting a role for macrophage MMPs is their association with evidence of collagen breakdown in vitro and in vivo.9,12,13 Increased MMP expression in the cells resident in atherosclerotic plaques has been attributed to lipid ingestion, stimulation by oxidized LDL, cytokines, hemodynamic stress, ligation of CD-40, infection, and increased expression of Tenascin-c.14–21 The MMP family of enzymes includes collagenases (MMP-1 or interstitial collagenase, MMP-8 or neutrophil collagenase, and MMP-13 or collagenase 3), gelatinases (MMP-2 or gelatinase A and MMP-9 or gelatinase B), stromelysins (MMP-3, MMP-10, and MMP-11), membrane-bound MMPs (MT-MMPs 1 through 4) matrilysin (MMP-7), and metalloelastase (MMP-12).In the present issue of Circulation, Herman et al22 report that MMP-8, also known as the neutrophil collagenase, is also expressed in human atherosclerotic plaques and that it colocalizes with sites of in situ type I collagen cleavage.22 A novel finding is that MMP-8 was found expressed in situ and in vitro by macrophages, smooth muscle cells, and endothelial cells. In vitro expression was induced by stimulation with interleukin-1β and CD-40 ligand, factors that have also been found to induce the expression of other MMPs in vascular cells and macrophages. Interestingly, the authors found that the MMP-8 produced by vascular cells and differentiated macrophages is secreted, as opposed to that produced by neutrophils, which is stored within intracellular granules. This distinctive feature, as well as the difference in the sizes reported for the MMP-8 produced by endothelial cells, smooth muscle cells, macrophages,22 and neutrophils, raise the interesting question of whether these substances represent various processed forms of the same MMP-8 zymogen or distinct variants of the neutrophil MMP-8, which has been previously shown to have alternatively spliced forms.23 On the basis of MMP-8's rather ubiquitous distribution in the plaques and colocalization with regions that stain immunopositive with an antibody to cleaved collagen, the authors propose that MMP-8 is involved in collagen breakdown and is thus likely a key player in plaque rupture. Their observations are consistent with the currently accepted hypothesis that MMPs contribute to plaque destabilization and rupture. Although much supporting experimental evidence has been gathered from a rather large number of studies of human and experimental atherosclerotic lesions demonstrating the expression and activity of MMPs,9,12 at this point, it is important to assess the current status of this hypothesis with a special emphasis on some of the fundamental questions that still await answers.A direct causal connection between the matrix-degrading action of MMPs and plaque rupture has yet to be demonstrated. One major obstacle for demonstrating such a relation is the fact that spontaneous plaque rupture with thrombosis has not been convincingly demonstrated in any of the many animal models of atherosclerosis, despite evidence of MMP expression in many of the human and experimental lesions. In fact, Lemaitre et al24 recently reported that overexpression of human interstitial collagenase (MMP-1) in apoE-null mice did not induce plaque rupture and actually resulted in an unexpected reduction of atherosclerosis. Similarly, MMP inhibition in experimental models of arterial injury has been shown to reduce collagen accumulation and neointimal growth, most likely due to inhibition of smooth muscle cell migration from the media. However, one could argue that although some of the animal models of atherosclerosis present many important features of the human lesion, none is yet displaying all the features and, thus, none is yet able to reproduce faithfully the history of the human lesion, including the final episode of plaque rupture. These considerations support the notion that although the action of MMPs may be necessary, it is by no means sufficient to destabilize an atherosclerotic lesion.Because 2 opposite metabolic processes determine the net amount of collagen, it is reasonable to propose that collagen synthesis is also important in determining plaque stability. Net collagen loss and cap thinning may, in fact, also require reduced collagen synthesis in the face of enhanced breakdown.2 Factors that decrease collagen synthesis and the death of smooth muscle cells, the main cellular source for matrix production, may contribute to such an event. A number of laboratories have, in fact, shown increased smooth muscle cell apoptosis in advanced atherosclerosis.25 Precise molecular signals and pathways responsible for smooth muscle cell death plaques are not known, although fas ligand and the epidermal growth factor (EGF)-like domain of Tenascin-c produced by macrophages (B.Z. Sharifi, PhD, unpublished observations, 2001) have been implicated.25Knowledge that may prove essential for the development of efficient therapeutic interventions for plaque stabilization relies on the answer to yet other unresolved issues of the MMP hypothesis. First, the identity of MMP(s) most likely to be responsible for weakening the plaque remains elusive, because a large repertoire of MMPs is expressed in human plaques.26 Because fibrillar collagen types I and III are the major structural components that confer tensile strength to the cap, the activity of enzymes capable of digesting this matrix component is regarded as especially consequential for plaque stability. Interstitial collagens have generally been considered resistant to proteolysis, except when attacked by interstitial collagenases, which cleave the triple helix into one-quarter and three-quarter fragments. These cleaved fragments then disintegrate into fragmented single α-chains, which are subject to further digestion by the gelatinases. Thus, on the basis of the traditional view that only interstitial collagenases can induce the first step in the breakdown of fibrillar collagen, Herman and colleagues22 propose that besides MMP-1 and MMP-13, which are already associated with the breakdown of interstitial collagen in the fibrous cap,12,13 MMP-8 must also be a key contributor.22 However, it is important to recognize that in addition to the traditional collagenases, the gelatinases MMP-2 and MMP-9 (major products of vascular and inflammatory cells) have also been shown to cleave intact fibrillar collagen, in addition to nonfibrillar and fragmented interstitial collagen27,28 and, thus, may be more important for matrix remodeling than previously thought. Relevant to the degradation of plaque collagen are previously reported observations of MMP-2 and MMP-9 overexpression and enzymatic activity within the vulnerable sites of human atheroma.9,12,29 Taken together, these findings can be used to build the hypothesis that gelatinases also participate in the degradation of the plaque's interstitial collagen, increasing the array of MMPs that may control plaque stability through this mechanism, which further illustrates the complexity of the question regarding the relative contributions of various MMPs.Another issue essential for potential attempts to inhibit the degrading action of MMPs is to tease out the mechanisms that lead to the in situ activation of the latent zymogens secreted by cells. The study by Herman et al22 did not investigate mechanisms that may activate the MMP-8 produced by vascular cells and macrophages. Although other MMPs have been shown to be activated by the reactive oxygen species produced by macrophages or activated vascular cells30 or by the MT-MMPs expressed by these cells,16 it is unclear if the same factors could lead to the generation of active MMP-8. Previous studies indicate that the activation of the neutrophil MMP-8 requires the action of hypochlorous acid, a product of neutrophils, and of cathepsin G.31 Although in the absence of neutrophils in vitro and in the plaque the potential source of hypochlorous acid remains unclear, the previous in situ localization of cathepsin S in the these lesions reported by the same laboratory offers potential pathways for MMP-8 activation.32Our understanding of factors and pathways leading to plaque rupture and subsequent thrombosis remains incomplete, and the current status of the MMP hypothesis certainly does not provide all the answers. Continued investigation of this critical area in vascular biology is warranted. The application of new investigative tools such as the comparative transcriptional profiling of diseased and nondiseased blood vessels, ruptured and nonruptured plaques, and plaques bearing features of vulnerability versus plaques with a more stable-appearing phenotype may yet identify unique genes and pathways involved in plaque rupture and thrombosis. Even then, the burden of proof will again rely on the development of appropriate models in which we can test options for the "holy grail" of therapeutic inhibition of plaque rupture. So, while the players keep piling up, questions remain.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.FootnotesCorrespondence to Dr P.K. Shah, Director, Division of Cardiology and Atherosclerosis Research Center, Room 5347, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048. E-mail [email protected] References 1 Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92: 657–671.CrossrefMedlineGoogle Scholar2 Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev. 2000; 8: 31–39.CrossrefMedlineGoogle Scholar3 Virmani R, Burke AP, Farb A. Plaque rupture and plaque erosion. Thromb Haemost. 1999; 82 (suppl 1): 1–3.Google Scholar4 Davies MJ, Woolf N, Rowles P, et al. Lipid and cellular constituents of unstable human aortic plaques. Basic Res Cardiol. 1994; 89: 33–39.MedlineGoogle Scholar5 Laine P, Kaartinen M, Penttila A, et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 1999; 99: 361–369.CrossrefMedlineGoogle Scholar6 Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. 2001; 103: 604–616.CrossrefMedlineGoogle Scholar7 Fishbein MC, Siegel RJ. How big are coronary atherosclerotic plaques that rupture? Circulation. 1996; 94: 2662–2666.CrossrefMedlineGoogle Scholar8 Henney AM, Wakeley PR, Davies MJ, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci UtStA. 1991; 88: 8154–8158.CrossrefMedlineGoogle Scholar9 Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994; 94: 2493–2503.CrossrefMedlineGoogle Scholar10 Brown DL, Hibbs MS, Kearney M, et al. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation. 1995; 91: 2125–2131.CrossrefMedlineGoogle Scholar11 Nikkari ST, O'Brien KD, Ferguson M, et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995; 92: 1393–1398.CrossrefMedlineGoogle Scholar12 Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995; 92: 1565–1569.MedlineGoogle Scholar13 Sukhova GK, Schonbeck U, Rabkin E, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999; 99: 2503–2509.CrossrefMedlineGoogle Scholar14 Galis ZS, Sukhova GK, Kranzhofer R, et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci UtStA. 1995; 92: 402–406.CrossrefMedlineGoogle Scholar15 Xu XP, Meisel SR, Ong JM, et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation. 1999; 99: 993–998.CrossrefMedlineGoogle Scholar16 Rajavashisth TB, Liao JK, Galis ZS, et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem. 1999; 274: 11924–11929.CrossrefMedlineGoogle Scholar17 Galis ZS, Muszynski M, Sukhova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994; 75: 181–189.CrossrefMedlineGoogle Scholar18 Lee RT, Schoen FJ, Loree HM, et al. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis: implications for plaque rupture. Arterioscler Thromb Vasc Biol. 1996; 16: 1070–1073.CrossrefMedlineGoogle Scholar19 Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 1997; 96: 396–399.CrossrefMedlineGoogle Scholar20 Kol A, Sukhova GK, Lichtman AH, et al. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation. 1998; 98: 300–307.CrossrefMedlineGoogle Scholar21 Wallner K, Li C, Shah PK, et al. Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation. 1999; 99: 1284–1289.CrossrefMedlineGoogle Scholar22 Herman MP, Sukhova GK, Libby P, et al. Expression of neutrophil collagenase (matrix mealloproteinase-8) in human atheroma: a novel collagenic pathway suggested by transcriptional profiling. Circulation. 2001; 104: 1899–1904.CrossrefMedlineGoogle Scholar23 Hu SI, Klein M, Carozza M, et al. Identification of a splice variant of neutrophil collagenase (MMP-8). FEBS Lett. 1999; 443: 8–10.CrossrefMedlineGoogle Scholar24 Lemaitre V, O'Byrne TK, Borczuk AC, et al. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest. 2001; 107: 1227–1234.CrossrefMedlineGoogle Scholar25 Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res. 1999; 41: 361–368.CrossrefMedlineGoogle Scholar26 Shah PK. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med. 1998; 3: 199–206.CrossrefMedlineGoogle Scholar27 Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase: inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 1995; 270: 5872–5876.CrossrefMedlineGoogle Scholar28 Kahari VM, Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol. 1997; 6: 199–213.CrossrefMedlineGoogle Scholar29 Li Z, Li L, Zielke HR, et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol. 1996; 148: 121–128.MedlineGoogle Scholar30 Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest. 1996; 98: 2572–2579.CrossrefMedlineGoogle Scholar31 Claesson R, Karlsson M, Zhang Y, et al. Relative role of chloramines, hypochlorous acid, and proteases in the activation of human polymorphonuclear leukocyte collagenase. J Leukoc Biol. 1996; 60: 598–602.CrossrefMedlineGoogle Scholar32 Sukhova GK, Shi GP, Simon DI, et al. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest. 1998; 102: 576–583.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Zeng G, Zhang Q, Wang X and Wu K (2022) Low-level plasticizer exposure and all-cause and cardiovascular disease mortality in the general population, Environmental Health, 10.1186/s12940-022-00841-3, 21:1, Online publication date: 1-Dec-2022. Kotlyarov S and Kotlyarova A (2022) Involvement of Fatty Acids and Their Metabolites in the Development of Inflammation in Atherosclerosis, International Journal of Molecular Sciences, 10.3390/ijms23031308, 23:3, (1308) Sofias A, De Lorenzi F, Peña Q, Azadkhah Shalmani A, Vucur M, Wang J, Kiessling F, Shi Y, Consolino L, Storm G and Lammers T (2021) Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders, Advanced Drug Delivery Reviews, 10.1016/j.addr.2021.113831, 175, (113831), Online publication date: 1-Aug-2021. Liu Y, Zhu Y, Jia W, Sun D, Zhao L, Zhang C, Wang C, Lyu Q, Chen Y, Chen G, Bo Y and Xing Y (2020) Association of the Total White Blood Cell, Neutrophils, and Monocytes Count With the Presence, Severity, and Types of Carotid Atherosclerotic Plaque, Frontiers in Medicine, 10.3389/fmed.2020.00313, 7 Jung S, Lee D, Jin H, Lee H, Ko H, Lee K, Kim S, Ryu Y, Choi W, Kim B and Won K (2020) Fetuin-B regulates vascular plaque rupture via TGF-β receptor-mediated Smad pathway in vascular smooth muscle cells, Pflügers Archiv - European Journal of Physiology, 10.1007/s00424-020-02385-2, 472:5, (571-581), Online publication date: 1-May-2020. Xiong Q, Wang Z, Yu Y, Wen Y, Suguro R, Mao Y and Zhu Y (2019) Hydrogen sulfide stabilizes atherosclerotic plaques in apolipoprotein E knockout mice, Pharmacological Research, 10.1016/j.phrs.2019.04.006, 144, (90-98), Online publication date: 1-Jun-2019. Shih M, Pan K, Liu C, Shen C and Cherng J (2018) Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression, Regulatory Toxicology and Pharmacology, 10.1016/j.yrtph.2017.12.021, 92, (333-337), Online publication date: 1-Feb-2018. Degendorfer G, Chuang C, Mariotti M, Hammer A, Hoefler G, Hägglund P, Malle E, Wise S and Davies M (2018) Exposure of tropoelastin to peroxynitrous acid gives high yields of nitrated tyrosine residues, di-tyrosine cross-links and altered protein structure and function, Free Radical Biology and Medicine, 10.1016/j.freeradbiomed.2017.11.019, 115, (219-231), Online publication date: 1-Feb-2018. Zhong Y, Feng J, Li J and Fan Z (2017)(2017) Curcumin prevents lipopolysaccharide-induced matrix metalloproteinase-2 activity via the Ras/MEK1/2 signaling pathway in rat vascular smooth muscle cells, Molecular Medicine Reports, 10.3892/mmr.2017.7037, 16:4, (4315-4319), Online publication date: 1-Oct-2017. De Caridi G, Massara M, Spinelli F, David A, Gangemi S, Fugetto F, Grande R, Butrico L, Stefanelli R, Colosimo M, de Franciscis S and Serra R (2015) Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia, International Wound Journal, 10.1111/iwj.12464, 13:4, (493-499), Online publication date: 1-Aug-2016. Degendorfer G, Chuang C, Kawasaki H, Hammer A, Malle E, Yamakura F and Davies M (2016) Peroxynitrite-mediated oxidation of plasma fibronectin, Free Radical Biology and Medicine, 10.1016/j.freeradbiomed.2016.06.013, 97, (602-615), Online publication date: 1-Aug-2016. Rao V, Rai V, Stoupa S, Subramanian S and Agrawal D (2016) Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis, Atherosclerosis, 10.1016/j.atherosclerosis.2016.03.021, 248, (160-169), Online publication date: 1-May-2016. Perrotta I, Sciangula A, Aquila S and Mazzulla S (2016) Matrix Metalloproteinase-9 Expression in Calcified Human Aortic Valves, Applied Immunohistochemistry & Molecular Morphology, 10.1097/PAI.0000000000000144, 24:2, (128-137), Online publication date: 1-Feb-2016. Zhang Y, Menon N, Li C, Chan V and Kang Y (2016) The role of bifurcation angles on collective smooth muscle cell biomechanics and the implication in atherosclerosis development, Biomaterials Science, 10.1039/C5BM00329F, 4:3, (430-438) Salajegheh A (2016) Matrix Metalloproteinase 2 (MMP2) Angiogenesis in Health, Disease and Malignancy, 10.1007/978-3-319-28140-7_31, (203-208), . Shih M, Pan K and Cherng J (2015) Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells, International Journal of Molecular Sciences, 10.3390/ijms161226131, 16:12, (28800-28811) Rao V, Rai V, Stoupa S and Agrawal D (2015) Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00378.2015, 309:6, (H1075-H1086), Online publication date: 15-Sep-2015. Kim Y, Bae J, Lee S, Park S and Kim C (2015) SIRT1 attenuates PAF-induced MMP-2 production via down-regulation of PAF receptor expression in vascular smooth muscle cells, Vascular Pharmacology, 10.1016/j.vph.2015.04.015, 72, (35-42), Online publication date: 1-Sep-2015. Hahn J, Kaushik D and Yong V (2015) The role of EMMPRIN in T cell biology and immunological diseases, Journal of Leukocyte Biology, 10.1189/jlb.3RU0215-045R, 98:1, (33-48), Online publication date: 1-Jul-2015. Yilmaz M, Tenekecioglu E, Arslan B, Bekler A, Ozluk O, Karaagac K, Agca F, Peker T and Akgumus A (2013) White Blood Cell Subtypes and Neutrophil–Lymphocyte Ratio in Prediction of Coronary Thrombus Formation in Non-ST-Segment Elevated Acute Coronary Syndrome, Clinical and Applied Thrombosis/Hemostasis, 10.1177/1076029613507337, 21:5, (446-452), Online publication date: 1-Jul-2015. Tenekecioglu E, Yilmaz M, Bekler A and Demir S (2015) Eosinophil count is related with coronary thrombus in non ST-elevated acute coronary syndrome, Biomedical Papers, 10.5507/bp.2014.039, 159:2, (266-271), Online publication date: 28-Jun-2015. Vacek T, Neamtu D and Tyagi S (2015) Effect of MMPs on Cardiovasculature and Blood Flow Atherosclerosis, 10.1002/9781118828533.ch36, (467-478) Vajapey R, Rini D, Walston J and Abadir P (2014) The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance, Frontiers in Physiology, 10.3389/fphys.2014.00439, 5 Smiljanic K, Obradovic M, Jovanovic A, Djordjevic J, Dobutovic B, Jevremovic D, Marche P and Isenovic E (2014) Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2, Molecular and Cellular Biochemistry, 10.1007/s11010-014-2151-y, 396:1-2, (147-160), Online publication date: 1-Nov-2014. ZHENG X, WANG Q, ZHANG Y, YANG D, LI D, TANG B, LI X, YANG Y and MA S (2014)(2014) Intermittent cold stress enhances features of atherosclerotic plaque instability in apolipoprotein E-deficient mice, Molecular Medicine Reports, 10.3892/mmr.2014.2464, 10:4, (1679-1684), Online publication date: 1-Oct-2014. Sini S, Deepa D, Harikrishnan S and Jayakumari N (2014) Evidence for an exclusive association of matrix metalloproteinase-9 with dysfunctional high-density lipoprotein: A novel finding, Atherosclerosis, 10.1016/j.atherosclerosis.2014.06.007, 236:1, (162-168), Online publication date: 1-Sep-2014. Rao V, Kansal V, Stoupa S and Agrawal D (2014) MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells, Physiological Reports, 10.1002/phy2.224, 2:2, (e00224), Online publication date: 1-Feb-2014. Kim Y, Lee S, Seo K, Bae J, Park S, Kim E, Bae S, Kim J and Kim C (2013) PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway, Journal of Lipid Research, 10.1194/jlr.M037176, 54:10, (2678-2686), Online publication date: 1-Oct-2013. Mullen L, Adams G, Fatah R, Gould D, Rigby A, Sclanders M, Koutsokeras A, Mittal G, Vessillier S and Chernajovsky Y (2013) Development of Latent Cytokine Fusion Proteins Fusion Protein Technologies for Biopharmaceuticals, 10.1002/9781118354599.ch16, (237-252) Signorelli S, Anzaldi M, Fiore V, Simili M, Puccia G, Libra M, Malaponte G and Neri S (2012) Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects, Cytokine, 10.1016/j.cyto.2012.04.038, 59:2, (294-298), Online publication date: 1-Aug-2012. Moreno P, Alviar C, Sanz J and Fuster V (2012) High-Risk Vulnerable Plaques Textbook of Interventional Cardiology, 10.1016/B978-1-4377-2358-8.00059-0, (809-841), . Peeters W, Moll F, Vink A, van der Spek P, de Kleijn D, de Vries J, Verheijen J, Newby A and Pasterkamp G (2011) Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome, European Heart Journal, 10.1093/eurheartj/ehq517, 32:18, (2314-2325), Online publication date: 1-Sep-2011., Online publication date: 1-Sep-2011. Phipps J, Hatami N, Galis Z, Baker J, Fishbein M and Marcu L (2011) A fluorescence lifetime spectroscopy study of matrix metalloproteinases-2 and -9 in human atherosclerotic plaque, Journal of Biophotonics, 10.1002/jbio.201100042, (n/a-n/a), Online publication date: 19-Jul-2011. Minear M, Crosslin D, Sutton B, Connelly J, Nelson S, Gadson-Watson S, Wang T, Seo D, Vance J, Sketch M, Haynes C, Goldschmidt-Clermont P, Shah S, Kraus W, Hauser E and Gregory S (2011) Polymorphic variants in tenascin-C (TNC) are associated with atherosclerosis and coronary artery disease, Human Genetics, 10.1007/s00439-011-0959-z, 129:6, (641-654), Online publication date: 1-Jun-2011. Gresele P, Falcinelli E, Loffredo F, Cimmino G, Corazzi T, Forte L, Guglielmini G, Momi S and Golino P (2010) Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation, European Heart Journal, 10.1093/eurheartj/ehq390, 32:3, (316-325), Online publication date: 1-Feb-2011., Online publication date: 1-Feb-2011. Heo S, Cho C, Kim H, Jo Y, Yoon K, Lee J, Park J, Park K, Ahn T, Chung K, Yoon S and Chang D (2011) Plaque Rupture is a Determinant of Vascular Events in Carotid Artery Atherosclerotic Disease: Involvement of Matrix Metalloproteinases 2 and 9, Journal of Clinical Neurology, 10.3988/jcn.2011.7.2.69, 7:2, (69), . Bansilal S and Fuster V (2011) Pathophysiology of coronary thrombosis Coronary Care Manual, 10.1016/B978-0-7295-3927-2.10009-0, (62-72), . Muhmmed Suliman M, Bahnacy Juma A, Ali Almadhani A, Pathare A, Alkindi S and Uwe Werner F (2010) Predictive Value of Neutrophil to Lymphocyte Ratio in Outcomes of Patients with Acute Coronary Syndrome, Archives of Medical Research, 10.1016/j.arcmed.2010.11.006, 41:8, (618-622), Online publication date: 1-Nov-2010. Sigala F, Savvari P, Liontos M, Sigalas P, Pateras I, Papalampros A, Basdra E, Kolettas E, Kotsinas A, Papavassiliou A and Gorgoulis V (2010) Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway, Journal of Cellular and Molecular Medicine, 10.1111/j.1582-4934.2010.01082.x, 14:9, (2273-2280), Online publication date: 1-